Live Breaking News & Updates on Dermtech Melanoma Test
Stay updated with breaking news from Dermtech melanoma test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,850,000 shares, a drop of 7.8% from the April 30th total of 3,090,000 shares. Based on an average daily volume of 599,200 shares, the short-interest ratio is […] ....
DermTech's (DMTK) Equal Weight Rating Reiterated at Stephens themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Lake Street Capital in a research report issued on Friday, Benzinga reports. They currently have a $0.63 price target on the stock. Lake Street Capital’s target price suggests a potential downside of 2.17% from the stock’s previous close. A […] ....
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Stephens in a research note issued on Friday, Benzinga reports. They presently have a $1.50 price objective on the stock. Stephens’ price target points to a potential upside of 132.92% from the company’s previous close. Separately, BTIG Research […] ....
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) fell 0.9% on Tuesday . The company traded as low as $0.60 and last traded at $0.61. 48,834 shares were traded during mid-day trading, a decline of 85% from the average session volume of 321,284 shares. The stock had previously closed at $0.62. Analyst Upgrades and Downgrades Separately, […] ....